NASDAQ:IDXG

Interpace Biosciences SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$8.35
+0.73 (+9.58 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.51
$8.85
50-Day Range
$3.00
$7.73
52-Week Range
$2.57
$8.50
Volume12,547 shs
Average Volume178,906 shs
Market Capitalization$34.27 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23

SEC Filings

Interpace Biosciences (NASDAQ:IDXG) SEC Filings

DateFilerForm TypeView
04/26/2021
7:52 AM
Interpace Biosciences (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
04/05/2021
5:30 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2021
5:14 AM
Interpace Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2021
5:02 AM
Interpace Biosciences (Filer)
Form NT 10-K
03/12/2021
3:57 PM
Freeburg Thomas John (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
4:06 PM
Interpace Biosciences (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/04/2021
3:49 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2021
3:48 PM
Interpace Biosciences (Filer)
Interpace Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/21/2021
3:49 PM
1315 Capital II, L.P. (Filed by)
Interpace Biosciences (Subject)
Form SC 13D/A
01/20/2021
7:55 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
8:43 PM
Interpace Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/19/2021
4:03 PM
Interpace Biosciences (Filer)
Form 10-Q/A
01/19/2021
3:59 PM
Interpace Biosciences (Filer)
Form 10-Q/A
01/19/2021
3:13 PM
Ampersand 2018 Limited Partnership (Filed by)
Interpace Biosciences (Subject)
Form SC 13D/A
01/11/2021
3:50 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
8:49 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
4:02 PM
Interpace Biosciences (Issuer)
STOVER JACK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
4:01 PM
Burnell Thomas W. (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
4:00 PM
Burnell Thomas W. (Reporting)
Interpace Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/25/2020
7:25 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2020
3:20 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2020
3:19 PM
Interpace Biosciences (Filer)
Form NT 10-Q
10/23/2020
3:01 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2020
7:35 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
4:13 PM
Interpace Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/14/2020
8:14 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2020
3:34 PM
Interpace Biosciences (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
08/20/2020
2:57 PM
Binsalamah Ziyad (Filed by)
Interpace Biosciences (Subject)
Form SC 13D/A
08/20/2020
7:45 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
4:23 PM
Interpace Biosciences (Filer)
Form NT 10-Q
08/14/2020
4:22 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2020
8:10 AM
Binsalamah Ziyad (Filed by)
Interpace Biosciences (Subject)
Form SC 13D
07/14/2020
3:20 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2020
9:50 AM
Gorman Robert J. (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
7:01 PM
Interpace Biosciences (Issuer)
SULLIVAN STEPHEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
6:59 PM
Interpace Biosciences (Issuer)
Rocca Fortunato R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
6:58 PM
Interpace Biosciences (Issuer)
KEEGAN JOSEPH D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
7:06 AM
Interpace Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2020
4:13 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2020
8:42 PM
Interpace Biosciences (Filer)
Form DEF 14A
06/09/2020
1:36 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
8:47 PM
Interpace Biosciences (Filer)
Form PRE 14A
05/14/2020
8:55 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2020
7:15 AM
1315 Capital II, L.P. (Filed by)
Interpace Biosciences (Subject)
Form SC 13D/A
04/27/2020
3:55 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
3:20 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
10:56 AM
Interpace Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/17/2020
3:36 PM
Interpace Biosciences (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
04/06/2020
4:46 PM
Interpace Biosciences (Issuer)
STOVER JACK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2020
10:32 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
9:19 AM
Interpace Biosciences (Issuer)
Lampe-Onnerud Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
9:18 AM
Interpace Biosciences (Issuer)
Lampe-Onnerud Christina (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/04/2020
9:15 AM
Interpace Biosciences (Issuer)
Marcet Pablo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
9:14 AM
Interpace Biosciences (Issuer)
Marcet Pablo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/03/2020
6:24 PM
Interpace Biosciences (Issuer)
Knechtel Fred S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
6:21 PM
Interpace Biosciences (Issuer)
Knechtel Fred S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2020
3:22 PM
Gorman Robert J. (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
3:19 PM
Early James (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
3:18 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:10 PM
Interpace Biosciences (Filer)
Form 8-K/A
01/28/2020
3:09 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
3:29 PM
Interpace Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
01/24/2020
3:34 PM
Interpace Biosciences (Issuer)
STOVER JACK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:30 PM
Interpace Biosciences (Issuer)
Richard Gregory (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
4:41 PM
1315 Capital II, L.P. (Filed by)
Interpace Biosciences (Subject)
Form SC 13D
01/23/2020
4:15 PM
1315 Capital II, L.P. (Reporting)
Interpace Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2020
4:12 PM
Chan Edward (Reporting)
Interpace Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/17/2020
3:21 PM
Interpace Biosciences (Issuer)
McCarthy Laurence (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:20 PM
Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:15 PM
Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
7:30 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
11:55 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
6:34 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
3:15 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:33 PM
Interpace Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2019
11:25 AM
Interpace Biosciences (Filer)
Form DEF 14A
11/01/2019
3:41 PM
Interpace Biosciences (Filer)
Form PRE 14A
10/28/2019
3:19 PM
Interpace Biosciences (Issuer)
McCarthy Laurence (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/28/2019
3:18 PM
Gorman Robert J. (Reporting)
Interpace Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/21/2019
6:41 PM
Interpace Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/21/2019
6:34 PM
Interpace Biosciences (Filer)
Form S-8 POS
10/18/2019
3:22 PM
Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2019
3:15 PM
Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
3:20 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
4:17 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:40 PM
Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:38 PM
Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
3:46 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
3:43 PM
Interpace Biosciences (Filer)
Form 424B5
09/19/2019
8:49 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
8:26 PM
Interpace Biosciences (Filer)
Form 8-K/A
08/22/2019
3:28 PM
Interpace Biosciences (Filer)
Form DEF 14A
08/13/2019
3:46 PM
Interpace Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2019
7:42 AM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
8:21 PM
Interpace Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
8:00 PM
Interpace Biosciences (Filer)
Form PRE 14A
07/26/2019
7:15 PM
Interpace Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
07/25/2019
3:56 PM
Ampersand 2018 Limited Partnership (Filed by)
Interpace Biosciences (Subject)
Form SC 13D
07/25/2019
3:05 PM
Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/25/2019
3:05 PM
Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.